Copyright
©2014 Baishideng Publishing Group Inc.
World J Methodol. Sep 26, 2014; 4(3): 163-188
Published online Sep 26, 2014. doi: 10.5662/wjm.v4.i3.163
Published online Sep 26, 2014. doi: 10.5662/wjm.v4.i3.163
Figure 2 The chemical structure of chelators in clinical use.
The chemical structures of the three orphan iron chelating drugs (A-C) which are used for the treatment of iron overload in thalassaemia and two other chelators used in other conditions (D and E): (A) deferoxamine (DF); (B) deferiprone (L1), (C) deferasirox (DFRA), (D) ethylenediaminetetraacetic acid (EDTA) and (E) diethylenetriaminepentaacetic acid (DTPA).
- Citation: Kontoghiorghe CN, Andreou N, Constantinou K, Kontoghiorghes GJ. World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients. World J Methodol 2014; 4(3): 163-188
- URL: https://www.wjgnet.com/2222-0682/full/v4/i3/163.htm
- DOI: https://dx.doi.org/10.5662/wjm.v4.i3.163